ApprovalTrail

Approval · Notice of Compliance 20902 · 2018

TORADOL: Notice of Compliance 20902

Issued May 28, 2018

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
20902
Date
May 28, 2018
Company
AA Pharma Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
To support an alternative manufacturing site for 10 mg tablets and to update the chemistry and manufacturing information as well as the bottle label

Products in this notice

BrandDINStatus today
TORADOLNot yet assigned—

Medicinal ingredients